MedPath

To compare the effectiveness of carbetocin and oxytocin in controlling blood loss when admisinstered during vaginal delivery

Not Applicable
Conditions
Health Condition 1: O721- Other immediate postpartum hemorrhage
Registration Number
CTRI/2023/04/052133
Lead Sponsor
Pondicherry Institute Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Pregnant women above the age of 21 years

2) Singleton term pregnancies ( >37 weeks of gestational age)

3) Live fetus- vertex presentation

Exclusion Criteria

1) Traumatic PPH

2) Placenta previa

3) Abruptio placenta

4) Severe pre-eclampsia

5) Severe anemia

6) Gestational thrombocytopenia, TTP, ITP

7) Sensitivity to oxytocin or carbetocin

8) Serious cardiovascular disorders, hepatic, renal disorders, epilepsy

9) Multiple pregnancies

10) Chorioamnionitis

11) Polyhydraminos

12) Macrosomia

13) History of previous postpartum hemorrhage

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath